Dr. Jan Loncke SRL
Dr. Jan Loncke reported total assets of 249,230 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
The score of Dr. Jan Loncke shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +148 % Total assets +55 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Jan Loncke's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 37,797 € | ||||
| Equity | 203,842 € | ||||
| Cash | 225,453 € | ||||
| EBITDA | 71,010 € | ||||
| Total assets | 249,230 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 23 Jul 2025
- Year ended 31 Dec 2023filed on 26 Jul 2024
- Year ended 31 Dec 2022filed on 28 Jul 2023
- Year ended 31 Dec 2021filed on 29 Jul 2022
Dr. Jan Loncke's financial analysis
- Solvency81.8%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Jan Loncke
Dr. Jan Loncke's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0771.340.337
- VAT number
- BE0771340337
- Peppol
- Registered · 0208:0771340337 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 13 Jul 2021
- Registered office
- 8000 Bruges
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Medical specialists activities (NACE 86220)
Dr. Jan Loncke (SRL) has been based in Bruges since 2021, active in: medical specialists activities. For 2025, it reports a net profit of 37,797 € and equity of 203,842 €; its revenue is not published. Its solvency stands at 81.8%, above the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. Jan Loncke
Companies in the same business, of comparable size and area, outside its group.
- Docteur Vinciane de VOS Medical specialists activities Visé · balance sheet 249,643 €
- Mars Medica Medical specialists activities Villers-la-Ville · balance sheet 248,356 €
- Reginster Diagnostic Medical specialists activities Liège · balance sheet 252,071 €
- Carsi Medical specialists activities Kortrijk · balance sheet 249,150 €
- IDS Gynecologie Medical specialists activities Brussels · balance sheet 249,047 €
- Carion Thierry Medical specialists activities Verviers · balance sheet 249,520 €
- Dr. Dimitri Verbruggen Orthopedie Medical specialists activities Oosterzele · balance sheet 249,563 €
- DR Gilliaux Philippe Medical specialists activities Momignies · balance sheet 249,582 €
Frequently asked questions about Dr. Jan Loncke
What is the revenue of Dr. Jan Loncke?
Dr. Jan Loncke files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Jan Loncke?
In Belgium, the VAT number is the company number prefixed with BE: BE0771340337 for Dr. Jan Loncke, if the company is VAT-registered. Its company number (CBE) is 0771.340.337.
Where is the registered office of Dr. Jan Loncke?
According to the CBE register, the registered office of Dr. Jan Loncke is in 8000 Bruges.
What is the equity of Dr. Jan Loncke?
At the close of the 2025 financial year, the equity of Dr. Jan Loncke amounts to 203,842 €, a solvency of 81.8% of total assets.
Who manages Dr. Jan Loncke?
The register lists 1 active mandates at Dr. Jan Loncke. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dr. Jan Loncke
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →